PHK
TCRR

Point72 Hong Kong’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History

Point72 Hong Kong’s Portfolio TCRR Stock Details TCRR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,741
Closed -$3K – 1851
2022
Q3 		$3K Buy
+1,741
New +$5.05K ﹤0.01% 1843
2022
Q2 		– Sell
-2,276
Closed -$6K – 2550
2022
Q1 		$6K Sell
2,276
-5,288
-70% -$16.6K ﹤0.01% 1670
2021
Q4 		$35K Sell
7,564
-3,459
-31% -$21.6K ﹤0.01% 1429
2021
Q3 		$94K Buy
11,023
+9,346
+557% +$132K ﹤0.01% 1364
2021
Q2 		$28K Sell
1,677
-232
-12% -$4.69K ﹤0.01% 1584
2021
Q1 		$42K Buy
+1,909
New +$52K ﹤0.01% 1318

Other funds holding TCRR

MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Point72 Hong Kong's TCRR Position: Q4 2022 in Review

Point72 Hong Kong sold out of TCR2 Therapeutics Inc. Common Stock (TCRR) in Q4 2022, closing a stake of 1,741 shares — an estimated $3K sold.

Point72 Hong Kong first reported a position in TCRR in Q1 2021 and held it in 6 quarters. The position peaked at $94K in Q3 2021. 63 funds tracked by Wall St. Rank hold TCRR as of Q4 2022.

  • Point72 Hong Kong reported no remaining TCR2 Therapeutics Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 1,741 TCR2 Therapeutics Inc. Common Stock shares in Q4 2022, an estimated $3K.
  • Point72 Hong Kong first reported a position in TCR2 Therapeutics Inc. Common Stock in Q1 2021 and held it in 6 quarters.
  • Point72 Hong Kong's TCR2 Therapeutics Inc. Common Stock position peaked at $94K in Q3 2021.
  • 63 funds tracked by Wall St. Rank held TCR2 Therapeutics Inc. Common Stock as of Q4 2022.

Based on Point72 Hong Kong's 13F filing for Q4 2022, filed 14 Feb 2023.